Mallinckrodt PLC (OTC Pink - Current Information:MNKKQ)

0.264
Delayed Data
As of 12:00am ET
 +0.0225 / +9.32%
Today’s Change
0.07
Today|||52-Week Range
3.66
+31.34%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$29.8M

Company Description

Mallinckrodt Plc engages in the development, manufacture, market, adn distribution of both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes innovative specialty pharmaceutical brands. The Specialty Generics segment relates to niche specialty generic drugs and active pharmaceutical ingredients. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Blanchardstown, Dublin.

Contact Information

Mallinckrodt Plc
College Business & Technology Park
Blanchardstown Dublin 15
P:(531) 696-0000
Investor Relations:

Employees

Shareholders

Individual stakeholders21.26%
Mutual fund holders1.72%
Other institutional0.18%

Top Executives

Mark C. TrudeauPresident, Chief Executive Officer & Director
Hugh M. OneillChief Operations & Commercial Officer, EVP
Bryan M. ReasonsChief Financial Officer & Executive Vice President
Steven Joseph RomanoChief Scientific Officer & Executive VP
Babatunde Adekunle OtulanaChief Medical Officer & Senior Vice President